retatrutide diabetes trial for type 1 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, people with 2 diabetes: a randomised, double-blind, placebo Retatrutide FDA Approval Status 2026:

It can be given in divided doses with meals, or as an extended-release formulation (Glucophage XR ) that is generally given once daily with the evening meal

How It Works Melanotan II binds to specific receptors in the body that regulate pigmentation and certain behaviors

Those peptides are FDA approved, but the ones being evaluated by the committee are not

Inositol and choline in lipid metabolism and insulin sensitivity

Lean muscle mass is the weight of the body that is not fat including muscles, bones, organs and more

This includes a peptide known as Melanotan II, a synthetic drug which stimulates the body's ability to produce melanin